Successful treatment of ifosfamide-induced hyponatremia with AVP receptor antagonist without interruption of hydration for prevention of hemorrhagic cystitis

Annals of Oncology

Volumn 20, Issue 7, 2009, Pages 1283-1285

  Glezerman, I G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONIVAPTAN; IFOSFAMIDE; MESNA; SODIUM; SODIUM CHLORIDE; URIC ACID;

ADULT; BOLUS INJECTION; CARCINOMATOUS MENINGITIS; CASE REPORT; CLINICAL FEATURE; CONTINUOUS INFUSION; FLUID INTAKE; HEADACHE; HEMORRHAGIC CYSTITIS; HUMAN; HYDRATION; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; LETTER; MALE; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; SERUM OSMOLALITY; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; URINE OSMOLALITY;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BENZAZEPINES; CYSTITIS; FLUID THERAPY; HUMANS; IFOSFAMIDE; INAPPROPRIATE ADH SYNDROME; LYMPHOMA, AIDS-RELATED; MALE; RECEPTORS, VASOPRESSIN;

EID: 67650345747     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp312     Document Type: Letter

References (5)

1. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007; 356(20): 2064-2072.
2. Raftopoulos H. Diagnosis and management of hyponatremia in cancer patients. Support Care Cancer 2007; 15(12): 1341-1347.
3. Cantwell BM, Idle M, Millward MJ et al. Encephalopathy with hyponatremia and inappropriate arginine vasopressin secretion following an intravenous ifosfamide infusion. Ann Oncol 1990; 1(3): 232.
4. Kirch C, Gachot B, Germann N et al. Recurrent ifosfamide-induced hyponatraemia. Eur J Cancer 1997; 33(14): 2438-2439.
5. Culine S, Ghosn M, Droz JP. Inappropriate antidiuretic hormone secretion induced by ifosfamide. Eur J Cancer 1990; 26(8): 922.